Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP302333.RAsVWF096FNhtttvEnojqGknuNSYHKqV2xO6_O9LGMvkg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP302333.RAsVWF096FNhtttvEnojqGknuNSYHKqV2xO6_O9LGMvkg130_assertion type Assertion NP302333.RAsVWF096FNhtttvEnojqGknuNSYHKqV2xO6_O9LGMvkg130_head.
- NP302333.RAsVWF096FNhtttvEnojqGknuNSYHKqV2xO6_O9LGMvkg130_assertion description "[Within this panel of paired lesions from the same patient, 14 of 15 (93%) low-grade tumors expressed the DCC protein, whereas only 7 of 15 (47%) corresponding glioblastomas were DCC positive.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP302333.RAsVWF096FNhtttvEnojqGknuNSYHKqV2xO6_O9LGMvkg130_provenance.
- NP302333.RAsVWF096FNhtttvEnojqGknuNSYHKqV2xO6_O9LGMvkg130_assertion evidence source_evidence_literature NP302333.RAsVWF096FNhtttvEnojqGknuNSYHKqV2xO6_O9LGMvkg130_provenance.
- NP302333.RAsVWF096FNhtttvEnojqGknuNSYHKqV2xO6_O9LGMvkg130_assertion SIO_000772 9012460 NP302333.RAsVWF096FNhtttvEnojqGknuNSYHKqV2xO6_O9LGMvkg130_provenance.
- NP302333.RAsVWF096FNhtttvEnojqGknuNSYHKqV2xO6_O9LGMvkg130_assertion wasDerivedFrom befree-20140225 NP302333.RAsVWF096FNhtttvEnojqGknuNSYHKqV2xO6_O9LGMvkg130_provenance.
- NP302333.RAsVWF096FNhtttvEnojqGknuNSYHKqV2xO6_O9LGMvkg130_assertion wasGeneratedBy ECO_0000203 NP302333.RAsVWF096FNhtttvEnojqGknuNSYHKqV2xO6_O9LGMvkg130_provenance.